Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOBLEOAK LIFE LIMITED Director's Dealing 2021

Oct 25, 2021

65433_rns_2021-10-25_dbfd25cf-6234-4f31-99d2-67972c213fdd.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NobleOak Life Limited

ABN 85 087 648 708

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director Anthony Ross Brown
Date of last notice 21 July 2021 (Appendix 3X)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Brohok Investments Co Pty Ltd ACN 000 730530 (an entity associated with Anthony Brown)(“Brohok”)
Date of change 25 October 2021
No. of securities held prior to change Direct:a) 1,404,145 NOL fully paid ordinary sharesb) 974,623 performance rights (granted undervarious LTIP schemes, not yet vested)c) 273,083 options (granted, not yet exercised)Indirect– Brohok:d) 3,980,769 NOL fully paid ordinary shares
Class a) Ordinary sharesb) Performance Rightsc) Optionsd) Ordinary shares
Number acquired a) 108,396 ordinary shares (which were issuedin respect of vested performance rights)
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1 ME_192089663_1

Appendix 3Y Change of Director’s Interest Notice

Number disposed Nil
Value/Consideration Estimated at $2.25 per share (estimate based on
Note: If consideration is non-cash, provide details andestimated valuation share price at market close on 22 October 2021)
No. of securities held after change Direct:
a) 1,512,541* NOL fully paid ordinary shares
b) 693,561** performance rights (granted, not
yet vested)
c) 273,083 options (granted, not yet exercised)
Indirect– Brohok:
d) 3,980,769 NOL fully paid ordinary shares
* includes 108,396 of the performance rights which
have been exercised and issued as NOL shares
** 172,666 of the performance rights lapsed and
have been cancelled
Nature of change Performance rights previously granted under a
Example: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment LTIP have partially vested / lapsed
plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change

  • See chapter 19 for defined terms.

Appendix 3Y Page 2 ME_192089663_1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3 ME_192089663_1